RESUMO
No disponible
Assuntos
Humanos , Testes de Fixação do Látex/métodos , Streptococcus pneumoniae/isolamento & purificação , Infecções Estreptocócicas/diagnósticoRESUMO
BACKGROUND AND OBJECTIVE: The aim of this study was to describe the evolution of serologically confirmed cases of mumps in the Madrid Community from 2000 to 2006. PATIENTS AND METHOD: Cases with data about age, sex and with samples obtained < or = 30 days after the onset of symptoms were included. IgM determination was performed by indirect ELISA (Enzygnost Mumps; Dade Behring). IgM positive cases were considered as confirmed. RESULTS: Information was available from 1,173 cases. Two hundred and fifty two of them (21.5%) were confirmed. The percentage of confirmed cases by year ranged between 21.4% and 27.2% (except for 2003 [10.7%], and 2004 [2.1%]). In the first years most confirmed cases corresponded to children (85.7% in 2000 and 68.6% in 2001) while in last years it was the opposite (10.7% in 2005 and 23.4% en 2006). CONCLUSIONS: These results indicate the appearance of 2 epidemic waves (in 2000--2002 and in 2005--2006). Currently, mumps should not be considered an exclusively pediatric disease.
Assuntos
Caxumba/epidemiologia , Adolescente , Adulto , Fatores Etários , Anticorpos Antivirais/sangue , Criança , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoglobulina M/sangue , Masculino , Caxumba/imunologia , Caxumba/prevenção & controle , Vacina contra Caxumba/administração & dosagem , Vírus da Caxumba/imunologia , Fatores Sexuais , Espanha/epidemiologiaRESUMO
Fundamento y objetivo: El objetivo de este estudio es describir la evolución de los casos de parotiditis confirmados serológicamente en la Comunidad de Madrid durante 2000-2006. Pacientes y método: Se seleccionaron los casos con datos de edad, sexo y cuyas muestras se extrajeron antes de 30 días desde el inicio de los síntomas. La determinación de la inmunoglobulina (Ig) M se realizó mediante enzimoinmunoanálisis indirecto (Enzygnost Parotiditis; Dade Behring). Se consideraron casos confirmados aquellos con IgM específica positiva. Resultados: Se dispuso de información de 1.173 casos y se confirmaron 252 (21,5%). El porcentaje de casos confirmados por año osciló entre el 21,4 y el 27,2% (excepto en 2003, que fue del 10,7%, y en 2004, que fue del 2,1%). En los primeros años, la mayoría de los casos confirmados correspondieron a niños (el 85,7% en 2000 y el 68,6% en 2001), mientras que en los últimos sucedió a la inversa (el 10,7% en 2005 y el 23,4% en 2006). Conclusiones: Estos resultados indican la aparición de 2 ondas epidémicas (en 2000-2002 y en 2005-2006). En la actualidad no debe considerarse la parotiditis como una enfermedad exclusivamente pediátrica
Background and objective: The aim of this study was to describe the evolution of serologically confirmed cases of mumps in the Madrid Community from 2000 to 2006. Patients and method: Cases with data about age, sex and with samples obtained # 30 days after the onset of symptoms were included. IgM determination was performed by indirect ELISA (Enzygnost Mumps; Dade Behring). IgM positive cases were considered as confirmed. Results: Information was available from 1,173 cases. Two hundred and fifty two of them (21.5%) were confirmed. The percentage of confirmed cases by year ranged between 21.4% and 27.2% (except for 2003 [10.7%], and 2004 [2.1%]). In the first years most confirmed cases corresponded to children (85.7% in 2000 and 68.6% in 2001) while in last years it was the opposite (10.7% in 2005 and 23.4% en 2006). Conclusions: These results indicate the appearance of 2 epidemic waves (in 2000-2002 and in 2005-2006). Currently, mumps should not be considered an exclusively pediatric disease
